Vyne Therapeutics Inc. · NASDAQ:VYNE

Citadel Advisors LLC reported a 7.20% stake in Vyne Therapeutics Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Citadel Advisors LLC reported a 7.20% stake in Vyne Therapeutics Inc., 1,100,329 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
7.20%
Shares
1,100,329
Intent
Passive
What changed
Stake changed
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC6.80%1,040,070
Citadel Advisors Holdings LP6.80%1,040,070
Citadel GP LLC6.80%1,040,070
Citadel Securities LLC0.40%58,260
Citadel Securities Group LP0.40%60,259
Citadel Securities GP LLC0.40%60,259
Kenneth Griffin7.20%1,100,329

Source

View original at SEC

Related